The chemistry and pharmacology of privileged pyrroloquinazolines

Bo Chao, Bingbing X. Li, Xiangshu Xiao

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The advent of next-generation sequencing (NGS) technology has plummeted the cost of whole genome sequencing, which has provided a long list of putative drug targets for a variety of diseases ranging from infectious diseases to cancers. The majority of these drug targets are still awaiting high-quality small molecule ligands to validate their therapeutic potential and track their druggability. Screening compound libraries based on privileged scaffolds is an efficient strategy to identify potential ligands to distinct biological targets. 7H-Pyrrolo[3,2-f]quinazoline (PQZ) is a potential privileged heterocyclic scaffold with diverse pharmacological properties. A number of biological targets have been identified for different derivatives of PQZ. This review summarized the synthetic strategies to access the chemical space associated with PQZ and discussed their unique biological profiles. This journal is

Original languageEnglish (US)
Pages (from-to)510-520
Number of pages11
JournalMedChemComm
Volume6
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Scaffolds
Pharmacology
Quinazolines
Ligands
Pharmaceutical Preparations
Libraries
Communicable Diseases
Screening
Genes
Genome
Technology
Derivatives
Costs and Cost Analysis
Molecules
Costs
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Pharmaceutical Science

Cite this

The chemistry and pharmacology of privileged pyrroloquinazolines. / Chao, Bo; Li, Bingbing X.; Xiao, Xiangshu.

In: MedChemComm, Vol. 6, No. 4, 01.04.2015, p. 510-520.

Research output: Contribution to journalArticle

Chao, Bo ; Li, Bingbing X. ; Xiao, Xiangshu. / The chemistry and pharmacology of privileged pyrroloquinazolines. In: MedChemComm. 2015 ; Vol. 6, No. 4. pp. 510-520.
@article{266b1fa40c0d4c9b916486a2d8b51a11,
title = "The chemistry and pharmacology of privileged pyrroloquinazolines",
abstract = "The advent of next-generation sequencing (NGS) technology has plummeted the cost of whole genome sequencing, which has provided a long list of putative drug targets for a variety of diseases ranging from infectious diseases to cancers. The majority of these drug targets are still awaiting high-quality small molecule ligands to validate their therapeutic potential and track their druggability. Screening compound libraries based on privileged scaffolds is an efficient strategy to identify potential ligands to distinct biological targets. 7H-Pyrrolo[3,2-f]quinazoline (PQZ) is a potential privileged heterocyclic scaffold with diverse pharmacological properties. A number of biological targets have been identified for different derivatives of PQZ. This review summarized the synthetic strategies to access the chemical space associated with PQZ and discussed their unique biological profiles. This journal is",
author = "Bo Chao and Li, {Bingbing X.} and Xiangshu Xiao",
year = "2015",
month = "4",
day = "1",
doi = "10.1039/c4md00485j",
language = "English (US)",
volume = "6",
pages = "510--520",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "Royal Society of Chemistry",
number = "4",

}

TY - JOUR

T1 - The chemistry and pharmacology of privileged pyrroloquinazolines

AU - Chao, Bo

AU - Li, Bingbing X.

AU - Xiao, Xiangshu

PY - 2015/4/1

Y1 - 2015/4/1

N2 - The advent of next-generation sequencing (NGS) technology has plummeted the cost of whole genome sequencing, which has provided a long list of putative drug targets for a variety of diseases ranging from infectious diseases to cancers. The majority of these drug targets are still awaiting high-quality small molecule ligands to validate their therapeutic potential and track their druggability. Screening compound libraries based on privileged scaffolds is an efficient strategy to identify potential ligands to distinct biological targets. 7H-Pyrrolo[3,2-f]quinazoline (PQZ) is a potential privileged heterocyclic scaffold with diverse pharmacological properties. A number of biological targets have been identified for different derivatives of PQZ. This review summarized the synthetic strategies to access the chemical space associated with PQZ and discussed their unique biological profiles. This journal is

AB - The advent of next-generation sequencing (NGS) technology has plummeted the cost of whole genome sequencing, which has provided a long list of putative drug targets for a variety of diseases ranging from infectious diseases to cancers. The majority of these drug targets are still awaiting high-quality small molecule ligands to validate their therapeutic potential and track their druggability. Screening compound libraries based on privileged scaffolds is an efficient strategy to identify potential ligands to distinct biological targets. 7H-Pyrrolo[3,2-f]quinazoline (PQZ) is a potential privileged heterocyclic scaffold with diverse pharmacological properties. A number of biological targets have been identified for different derivatives of PQZ. This review summarized the synthetic strategies to access the chemical space associated with PQZ and discussed their unique biological profiles. This journal is

UR - http://www.scopus.com/inward/record.url?scp=84928035023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928035023&partnerID=8YFLogxK

U2 - 10.1039/c4md00485j

DO - 10.1039/c4md00485j

M3 - Article

VL - 6

SP - 510

EP - 520

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 4

ER -